Gen9, Inc., a pioneer in the development of scalable technologies for synthesizing genes, and Agilent Technologies (NYSE: A) today announced the closing of a $21 million strategic investment from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results